BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3266915)

  • 1. Azimexone and cysteine hydrazide in the treatment of allergic encephalomyelitis.
    Błaszczyk B; Giełdanowski J; Woźniak M; Dobryszycka W; Lemmel EM; Katkiewicz M; Viljanen M
    Arch Immunol Ther Exp (Warsz); 1988; 36(3):217-27. PubMed ID: 3266915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of immunological reactivity in the course of allergic encephalomyelitis by isoprinosine.
    Giełdanowski J; Viljanen M; Molnar G; Błaszczyk B; Katkiewicz M; Karakoz I; Krawczyk E; Lemmel EM
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):789-96. PubMed ID: 2421687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental allergic encephalomyelitis in the chicken. Class-specific antibody to myelin basic protein, the ability of T cells to cause GvH reaction, brain and spleen histology, and nonspecific biochemical indicators of inflammation.
    Błaszczyk B; Viljanen MK; Molnar G; Giełodanowski J; Katkiewicz M; Hraba T; Krawczyk E
    Arch Immunol Ther Exp (Warsz); 1984; 32(6):703-9. PubMed ID: 6085612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental allergic encephalomyelitis in chickens.
    Błaszczyk B; Giełdanowski J; Karakoz I
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):743-6. PubMed ID: 312083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide in allergic encephalomyelitis in chickens.
    Błaszczyk B; Giełdanowski J; Viljanen M; Karakoz I; Katkiewicz M; Lemmel EM
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):369-75. PubMed ID: 3592938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of circulating antibodies on the formation of inflammatory reaction in allergic encephalomyelitis].
    Wajgt A
    Neuropatol Pol; 1973; 11(5):235-44. PubMed ID: 4759159
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavior of haptoglobin in experimental allergic encephalomyelitis in chickens.
    Woźniak M; Błaszczyk B; Krawczyk E; Dobryszycka W
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):783-8. PubMed ID: 2421686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies in the pathogenesis of demyelination in chronic relapsing EAE (cr-EAE).
    Lassmann H; Suchanek G; Kitz K; Stemberger H; Schwerer B; Bernheimer H
    Prog Clin Biol Res; 1984; 146():165-70. PubMed ID: 6718423
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral immune response in chronic relapsing experimental allergic encephalomyelitis (r-EAE) in guinea pigs.
    Olsson T; Henriksson A; Link H; Kristensson K
    Prog Clin Biol Res; 1984; 146():179-86. PubMed ID: 6201888
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aspects of the value of humoral antibodies in encephalomyelitis of neuroallergic origin].
    Hitzschke B; Günther J; Meyer-Rienecker HJ
    Psychiatr Neurol Med Psychol (Leipz); 1975 Jan; 27(1):1-15. PubMed ID: 178016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive induction of experimental allergic encephalomyelitis.
    Stromnes IM; Goverman JM
    Nat Protoc; 2006; 1(4):1952-60. PubMed ID: 17487182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature of factors in chronic relapsing EAE and MS sera which induce myelinotoxicity and cellular changes in organ culture.
    Bradbury K; Suckling AJ
    Prog Clin Biol Res; 1984; 146():193-8. PubMed ID: 6201890
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental allergic encephalomyelitis in rhesus monkeys: I. Immunological parameters in EAE resistant and susceptible rhesus monkeys.
    van Lambalgen R; Jonker M
    Clin Exp Immunol; 1987 Apr; 68(1):100-7. PubMed ID: 3652511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin-fixing antibody in experimental allergic encephalomyelitis.
    Falk GA; Heinze RG; Kies MW; Alvord EC
    J Immunol; 1968 Feb; 100(2):321-8. PubMed ID: 5639700
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro synthesis of immunoglobulins and autoantibodies by lymphocytes from various body compartments during chronic relapsing experimental allergic encephalomyelitis.
    Olsson T; Henriksson A; Link H
    J Neuroimmunol; 1985 Sep; 9(5):293-305. PubMed ID: 2410454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoral immune response to MBP during the course of chronic relapsing EAE.
    Schwerer B; Schuller-Levis GB; Mehta PD; Madrid RE; Wisniewski HM
    Prog Clin Biol Res; 1984; 146():187-92. PubMed ID: 6201889
    [No Abstract]   [Full Text] [Related]  

  • 19. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
    Alvord EC
    Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
    [No Abstract]   [Full Text] [Related]  

  • 20. The model of allergic encephalomyelitis of nonacute, phase course.
    Błaszczyk B; Giełdanowski J; Viljanen MK; Dobryszycka W; Katkiewicz M
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):449-58. PubMed ID: 2639641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.